GoodRx Holdings, Inc. (GDRX): Valuation
TTM figures as of June 30, 2026
GoodRx Holdings, Inc. trades at 71.2 times trailing earnings and a 17.04% free-cash-flow yield. On P/E that is higher than 57% of its own month-end history back to 2020. The Healthcare median P/E is 22.9.
Earnings yield 1.41%. Shareholder yield 7.35%. ROIC 4.5%. Net debt $190.5M.
72 month-end valuation observations are on file, starting September 2020.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is GDRX cheap versus its own history?
GoodRx Holdings, Inc. trades at 71.2 times trailing earnings and a 17.04% free-cash-flow yield. On P/E that is higher than 57% of its own month-end history back to 2020. The Healthcare median P/E is 22.9.
What is GDRX's free-cash-flow yield?
GoodRx Holdings, Inc. currently yields 17.04% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.